The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 31, 2015
Filed:
Apr. 22, 2010
Applicants:
Hideyuki Akaza, Tokyo, JP;
Seiji Naito, Fukuoka, JP;
Toshinori Oka, Tokushima, JP;
Inventors:
Assignee:
Taiho Pharmaceutical Co., Ltd., Tokyo, JP;
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61P 35/00 (2006.01); A61K 31/513 (2006.01); G01N 33/68 (2006.01); C12Q 1/68 (2006.01); G01N 33/574 (2006.01);
U.S. Cl.
CPC ...
A61K 31/513 (2013.01); A61K 2300/00 (2013.01); C12N 2320/31 (2013.01); G01N 33/57438 (2013.01); G01N 2333/91017 (2013.01); G01N 2800/52 (2013.01);
Abstract
The present invention developed a novel antitumor agent for renal cell carcinoma that cannot be fully treated by the existing therapies. The present invention provides an antitumor agent comprising a combination drug of tegafur/gimeracil/oteracil potassium that ensures an excellent therapeutic effect in renal cell carcinoma patients that is superior to that of the existing therapies, by way of selecting the patients based on thymidylate synthase.